Exploring hidden determinants of splicing with genome-targeted proximity labeling
通过基因组靶向邻近标记探索剪接的隐藏决定因素
基本信息
- 批准号:10245896
- 负责人:
- 金额:$ 158.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-23 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingBiologyCellsChromatinCodeDNADiseaseEngineeringEpigenetic ProcessGene ExpressionGenesGenomeGenomic SegmentGenomicsGoalsHomeostasisHumanIntronsLabelMalignant NeoplasmsNatureNormal tissue morphologyOutcomePatternPopulationProcessProteinsProteomicsRNARNA SplicingRegulationReporterRoleSystemTherapeutic InterventionTranscriptdesignepigenomehuman diseaseinsightintegration site
项目摘要
PROJECT SUMMARY/ABSTRACT
The vast majority of human genes are multi-exonic and undergo alternative splicing to generate a several-
fold increase in the variety of transcripts and proteins that are produced. In diseases like cancer, splicing is often
globally aberrant and highly distinct from normal tissues, with increased levels of intron retention, alternative
splicing and usage of de novo splicing junctions. A fundamental unanswered question in RNA biology is how the
many layers that comprise the splicing code are interpreted to produce a given splicing outcome, and how these
processes become dysregulated in human diseases. The extensive crosstalk between processes occurring on
the DNA and those that act on the RNA suggest the chromatin state in particular may participate in orchestrating
alternative splicing. We have observed that random genomic integration of a splicing reporter construct results
in populations of cells corresponding to each possible splicing outcome, suggesting the genomic context at the
site of integration exerts a powerful influence on splicing. However, due primarily to technological limitations,
much remains unknown about the precise nature of the regulatory interplay between chromatin and RNA splicing
and the potential factors that may be involved. The goal of this proposal is to address the current challenges
impeding de novo discovery and develop unbiased experimental approaches to reveal hidden determinants of
splicing regulation at the chromatin level. Our approach is designed to directly connect splicing outcome with
unbiased proteomic profiling of the associated genomic region, in order to identify all of the potential chromatin
features that are involved in enforcing a particular pattern of splicing. We also propose to engineer new systems
to functionally validate a direct role for the epigenome in splicing regulation and to modulate splicing at will. Our
findings have implications for both epigenetics and RNA biology, and in particular, how their interactions
influence the various processes involved in gene expression. It also has the potential to shed insight into the
causes and consequences of the widespread epigenetic and splicing dysregulation observed in human cancer.
Importantly, our approach is not limited to the study of splicing and will also enable unbiased discovery of the
mechanisms involved in other fundamental processes.
项目总结/文摘
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter S. Choi其他文献
Peter S. Choi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter S. Choi', 18)}}的其他基金
Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis
研究 RBM10 调节的选择性剪接在肺肿瘤发生中的作用
- 批准号:
10083717 - 财政年份:2019
- 资助金额:
$ 158.4万 - 项目类别:
Defining the role of RBM10 in RNA processing and tumor suppression
定义 RBM10 在 RNA 加工和肿瘤抑制中的作用
- 批准号:
8983196 - 财政年份:2015
- 资助金额:
$ 158.4万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Operating Grants
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 158.4万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 158.4万 - 项目类别:
Research Grants